CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Evotec SE is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Evotec SE
Essener Bogen 7
Phone: +49 40560810p:+49 40560810 HAMBURG, 22419  Germany Ticker: EVTEVT

Business Summary
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairwoman of the Supervisory Board IrisLoew-Friedrich 63 6/15/2021 6/17/2014
Independent Vice Chairman of the Supervisory Board RolandSackers 54 6/15/2021 6/19/2019
Chief Financial Officer, Member of the Management Board LaetitiaRouxel 49 4/1/2023 4/1/2023
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Cyprotex PLC 15 Beech Lane Macclesfield United Kingdom
Rigenerand Srl Via Dei Maestri Del Lavoro 4 Medolla Italy
Renovis, Inc. Two Corporate Drive South San Francisco CA United States
3 additional Subsidiary records available in full report.

Business Names
Business Name
0IRF
30
Aptuit (Oxford) Ltd.
41 additional Business Names available in full report.

General Information
Number of Employees: 5,086 (As of 9/30/2023)
Outstanding Shares: 177,292,182 (As of 1/31/2024)
Shareholders: 45,455
Stock Exchange: ETR
Fax Number: +49 4056081222


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, March 27, 2024